Dvbsbsnananan HÁ TĨNH - THI THỬ T...,indicate the best answer to each of,the following questions from 23 to,25.,Russia is on track to introduce its first cancer vaccine by early 2025, marking a significant,milestone in medical innovation. This vaccine is developed by a Russian team in collaboration with,major research institutions, including the Moscow State University and the Cancer Research Institute. It,uses cutting-edge mRNA technology, which has already proven effective in COVID-19 vaccines, to,target specific tumor cells and stimulate the body's immune response to fight cancer more effectively.,The vaccine is currently undergoing the final stages of clinical trials. These trials are designed to,evaluate its safety and efficacy in treating certain types of cancers, particularly those related to lung and,liver, which are among the most common globally. Preliminary results suggest that this vaccine could,significantly improve survival rates and reduce recurrence risks for cancer patients, bringing hope to,millions worldwide.,However, accessibility and affordability remain critical concerns. Experts highlight the potential,challenge of high production costs, which may limit access to this life-saving innovation in lower-income,regions. To address this, Russia is exploring partnerships with global health organizations and,pharmaceutical companies to scale production and distribution. This effort aims to make the vaccine,available to a broader population and integrate it into public health systems.,The introduction of this vaccine aligns with the growing global momentum in cancer,prevention and treatment. Similar initiatives, such as trials conducted by BioNTech in the UK,,underline the global effort to combat cancer with advanced technologies. If successful, Russia's vaccine,could complement these efforts, marking a new era in the fight against one of the world's leading causes,of death.,Question 23: Which of the following is NOT a feature of Russia's cancer vaccine?,A. It uses mRNA technology. B. It is undergoing clinical trials.,C. It predicts specific cancer types. D. It improves immune response to tumors.,Question 24: The word its in paragraph 2 refers to_____.,A. the vaccine B. the trial C. the stage D. the disease,Question 25: The word preliminary in paragraph 2 could best be replaced by_____.,A. initial B. final C. conclusive D. secondary,

Question

Dvbsbsnananan HÁ TĨNH - THI THỬ T...,indicate the best answer to each of,the following questions from 23 to,25.,Russia is on track to introduce its first cancer vaccine by early 2025, marking a significant,milestone in medical innovation. This vaccine is developed by a Russian team in collaboration with,major research institutions, including the Moscow State University and the Cancer Research Institute. It,uses cutting-edge mRNA technology, which has already proven effective in COVID-19 vaccines, to,target specific tumor cells and stimulate the body&#x27;s immune response to fight cancer more effectively.,The vaccine is currently undergoing the final stages of clinical trials. These trials are designed to,evaluate its safety and efficacy in treating certain types of cancers, particularly those related to lung and,liver, which are among the most common globally. Preliminary results suggest that this vaccine could,significantly improve survival rates and reduce recurrence risks for cancer patients, bringing hope to,millions worldwide.,However, accessibility and affordability remain critical concerns. Experts highlight the potential,challenge of high production costs, which may limit access to this life-saving innovation in lower-income,regions. To address this, Russia is exploring partnerships with global health organizations and,pharmaceutical companies to scale production and distribution. This effort aims to make the vaccine,available to a broader population and integrate it into public health systems.,The introduction of this vaccine aligns with the growing global momentum in cancer,prevention and treatment. Similar initiatives, such as trials conducted by BioNTech in the UK,,underline the global effort to combat cancer with advanced technologies. If successful, Russia&#x27;s vaccine,could complement these efforts, marking a new era in the fight against one of the world&#x27;s leading causes,of death.,Question 23: Which of the following is NOT a feature of Russia&#x27;s cancer vaccine?,A. It uses mRNA technology. B. It is undergoing clinical trials.,C. It predicts specific cancer types. D. It improves immune response to tumors.,Question 24: The word its in paragraph 2 refers to_____.,A. the vaccine B. the trial C. the stage D. the disease,Question 25: The word preliminary in paragraph 2 could best be replaced by_____.,A. initial B. final C. conclusive D. secondary,<img src=https://minio.ftech.ai/cvdata/fqa/prod/public/illustration_images/3be0468daa03411da625f8bad0dc71eb.jpg />

Accepted Answer

{"userId": 5341157, "userName": "Hoai Anh "}c
A
A nhé bạn